Chemistry:Suvizumab

From HandWiki

Revision as of 12:02, 1 January 2022 by imported>MainEditor

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Suvizumab
Monoclonal antibody
Type	Whole antibody
Source	Humanized
Target	HIV-1
Clinical data
ATC code	none
Identifiers
CAS Number	914257-21-9^N
ChemSpider	none
UNII	4AJ2TI6DPI
^NY (what is this?) (verify)

Suvizumab is an antiviral and immunomodulator. It binds to HIV-1.^[1]^[2]

References

↑ "Proposed List number 102 of International Nonproprietary Names". WHO Drug Information (Geneva: World Health Organization) 23 (4): 344. 2009. ISSN 1010-9609. https://www.who.int/entity/medicines/publications/druginformation/innlists/PL_102.pdf.
↑ (in Swedish) Mikrobiologi III: immunsystem. Cambridge Stanford Books. https://books.google.se/books?id=VKP5DwAAQBAJ&pg=PT118&dq=Suvizumab.

Monoclonal antibodies for infectious disease and toxins

Fungal ("-fung-")

Human ("-fungu-")	Efungumab^†

Viral ("-v(i)[r]-")

Human ("-viru-")	Diridavumab^§ Exbivirumab^§ Foravirumab^§ Libivirumab^§ Rafivirumab^§ Regavirumab^§ Sevirumab^† Suptavumab Tuvirumab^§
Chimeric ("-vixi-")	Cosfroviximab Larcaviximab Porgaviximab
Humanized ("-vizu-")	Felvizumab^§ Lenvervimab^† Motavizumab^† Palivizumab Suvizumab^§

Bacterial ("-ba(c)-")

Human ("-bacu-")	Nebacumab Panobacumab^§ Raxibacumab
Mouse ("-baco-")	Edobacomab^§
Chimeric ("-baxi-")	Pagibaximab^†
Humanized ("-bazu-")	Tefibazumab^†

Toxin ("-tox(a)-")

Human ("-toxu-")	Actoxumab^§ Bezlotoxumab Suvratoxumab
Chimeric ("-toxaxi-")	Obiltoxaximab
Humanized ("-toxazu-")	Urtoxazumab^§

^#WHO-EM
^‡Withdrawn from market
Clinical trials:
- ^†Phase III
- ^§Never to phase III

0.00

(0 votes)

Original source: https://en.wikipedia.org/wiki/Suvizumab. Read more

Retrieved from "https://handwiki.org/wiki/index.php?title=Chemistry:Suvizumab&oldid=891138"

Experimental drugs